Professor Daly joined FIMM from the Broad Institute of MIT and Harvard and Massachusetts General Hospital. Here he discusses his research and the reasons he chose to move to Finland from the USA

The EMBL Director General, who steps down from his role at the end of 2018, has been named as the Director of Human Technopole

In the 'Behind the Scenes' series, we will look in-depth at a researcher, or a facility, within the Nordic EMBL Partnership. In our first article, we interview DANDRITE group leader, Duda Kvitsiani, about his work and the questions that he is trying to answer with his research. We also interviewed Dr Kvitsiani's PhD student, Juliane Martin, about her research project.

Oliver Billker joined MIMS as Director in October 2018. He was previously a senior group leader at the Wellcome Trust Sanger Institute and one of the lead investigators for their PlasmoGEM Malaria Programme project. Here, he tells us a bit more about his research, and what he hopes to achieve in his time at Umeå. Billker also holds a professorship at the Department of Molecular Biology, Umeå University.

The Nordic EMBL Partnership is very pleased to announce that Professor Poul Nissen, Director of DANDRITE (Danish Research Institute of Translational Neuroscience) has been named as the third speaker of the Nordic EMBL Partnership

NCMM hosts the 9th annual Nordic EMBL Partnership Meeting in the hills above Oslo. The annual Partnership meetings offer researchers an opportunity to come together for a programme of scientific discussion and networking.

NCMM has appointed new group leaders in precision medicine and systems medicine

We interviewed FIMM Group Leader, Caroline Heckman, about her research into personalised cancer treatments, and how useful and important it is to collaborate with other researchers, both within FIMM and across the wider Nordic EMBL Partnership

The four Nordic EMBL Directors were interviewed alongside Silke Schumacher, Director of International Relations at EMBL (European Molecular Biology Laboratory)

Hosted by Finnish Nordic EMBL Partner, FIMM (Institute for Molecular Medicine Finland), the 8th annual Nordic EMBL Partnership for Molecular Medicine Meeting 2017 took place from 4-7 September in Helsinki